Tähtinen, S., Grönberg-Vähä-Koskela, S., Lumen, D., Merisalo-Soikkeli, M., Siurala, M., Airaksinen, A. J., . . . Hemminki, A. (2015). Oncolytic adenovirus improves anti-tumor efficacy of adoptive T cell therapy by breaking tumor-induced immunosuppression and peripheral tolerance. J Immunother Cancer.
Chicago Stili AlıntıTähtinen, Siri, Susanna Grönberg-Vähä-Koskela, Dave Lumen, Maiju Merisalo-Soikkeli, Mikko Siurala, Anu J. Airaksinen, Markus Vähä-Koskela, ve Akseli Hemminki. "Oncolytic Adenovirus Improves Anti-tumor Efficacy of Adoptive T Cell Therapy By Breaking Tumor-induced Immunosuppression and Peripheral Tolerance." J Immunother Cancer 2015.
MLA AlıntıTähtinen, Siri, et al. "Oncolytic Adenovirus Improves Anti-tumor Efficacy of Adoptive T Cell Therapy By Breaking Tumor-induced Immunosuppression and Peripheral Tolerance." J Immunother Cancer 2015.